ahlam1399
07-28-2015, 05:32 AM
Glenmark Pharmaceuticals? Finacea generic infringes Bayer patent: court
NEW YORK (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2.img (http://da.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/ach.img (http://adchoice.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/ach.htm)http://pi.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2t.imghttp://pi2.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/487bc155/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=fTG6rdNEoCk:JzFv0W0qXwo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=fTG6rdNEoCk:JzFv0W0qXwo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/fTG6rdNEoCk
NEW YORK (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2.img (http://da.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/ach.img (http://adchoice.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/ach.htm)http://pi.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2t.imghttp://pi2.feedsportal.com/r/234566182691/u/49/f/654207/c/35217/s/487bc155/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/487bc155/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=fTG6rdNEoCk:JzFv0W0qXwo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=fTG6rdNEoCk:JzFv0W0qXwo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=fTG6rdNEoCk:JzFv0W0qXwo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/fTG6rdNEoCk